Products
Platform
Research
Market
Learn
Glenmark Pharmaceuticals Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
Total Qtr Revenue cr | 6,247.50 | 3,290.88 | 3,267.89 | 3,418.68 | 3,473.21 |
| Other Income Qtr Cr | 200.63 | 26.44 | 11.68 | 31.13 | 39.42 |
| Operating Revenues Qtr | 6,046.87 | 3,264.44 | 3,256.21 | 3,387.55 | 3,433.80 |
Loading chart... | |||||
Operating Expenses Qtr | 3,687.32 | 2,683.92 | 2,695.18 | 2,787.32 | 2,831.88 |
Operating Profit Qtr | 2,359.55 | 580.52 | 561.02 | 600.23 | 601.91 |
EBITDA Qtr Cr | 1,175.06 | 283.73 | 199.89 | 631.36 | 641.33 |
Depreciation Qtr | 141.20 | 129.93 | 125.20 | 122.74 | 120.28 |
Net Profit Qtr | 610.35 | 46.87 | 4.65 | 347.96 | 354.21 |
Basic EPS Qtr | 21.63 | 1.66 | 0.16 | 12.33 | 12.55 |
Open Demat Account
Open Demat Account